Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Methylatropine is an antagonist of muscarinic acetylcholine receptors (IC50 = <0.1 nM in a radioligand binding assay using isolated porcine brain membranes) and a derivative of atropine (Item No. 12008).1,2 It reduces acetylcholine-induced decreases in blood pressure in rats when administered intravenously with an ED50 value of 5.5 µg/kg.2 Methylatropine reduces salivation, induces mydriasis, and increases heart rate in dogs.3
WARNING This product is not for human or veterinary use.
1. Binding of tropane alkaloids to nicotinic and muscarinic acetylcholine receptors. Pharmazie 50(7), 493-495 (1995).
2. A comparison of the central and peripheral antimuscarinic effects of atropine and methylatropine injected systemically and into the cerebral ventricles. Life Sci. 42(8), 905-911 (1988).
3. Central and peripheral effects of anticholinergic compounds. Acta Pharmacol. Toxicol. (Copenh) 28(4), 305-326 (1970).